Efficacy of the barley-based remedy in the treatment of novel corona

Efficacy of the barley-based remedy in the treatment of suspected novel coronavirus (COVID-19) pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180923041093N4

Enrollment

Registered

2020-03-28

Start date

2020-04-02

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19

Interventions

Intervention 1: Intervention group: Patients in this group receive the treatment according to the protocol of the Ministry of Health, in addition they should daily boil the contents of one drug pack w

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18-65 years old Developed mild to moderate COVID-19 based on Ministry of Health protocol Candidate for outpatient treatment

Exclusion criteria

Exclusion criteria: Asthma or allergy Hypertension Diabetes Pregnancy/lactation CHF Chronic renal failure ChemotherapyT aking Corticosteroid Immune deficiency

Design outcomes

Primary

Measure	Time frame
Temperature. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Termometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Muscular pain. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute.	—

Measure

Time frame

Temperature. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Termometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Muscular pain. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute.

—

Secondary

Measure	Time frame
Hospital admission. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of admission to total patients in each group.;Mortality. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of deaths to total patients in each group.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Azimi

Kerman University of Medical Sciences

dr.azimm@gmail.com+98 34 3211 0860

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026